BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10452976)

  • 1. Inefficient phospholipase C activation and reduced Lck expression characterize the signaling defect of umbilical cord T lymphocytes.
    Miscia S; Di Baldassarre A; Sabatino G; Bonvini E; Rana RA; Vitale M; Di Valerio V; Manzoli FA
    J Immunol; 1999 Sep; 163(5):2416-24. PubMed ID: 10452976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
    Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
    Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
    Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
    Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.
    Rabinowich H; Banks M; Reichert TE; Logan TF; Kirkwood JM; Whiteside TL
    Clin Cancer Res; 1996 Aug; 2(8):1263-74. PubMed ID: 9816296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of p56(lck) to p60(lck) in human peripheral blood T lymphocytes is dependent on co- stimulation through accessory receptors: involvement of phospholipase C, protein kinase C and MAP-kinases in vivo.
    Schröder AJ; Quehl P; Müller J; Samstag Y
    Eur J Immunol; 2000 Feb; 30(2):635-43. PubMed ID: 10671221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic PMA treatment of Jurkat T lymphocytes results in decreased protein tyrosine phosphorylation and inhibition of CD3- but not Ti-dependent antibody-triggered Ca2+ signaling.
    Ahnadi CE; Giguère P; Gravel S; Gagné D; Goulet AC; Fülöp T; Payet MD; Dupuis G
    J Leukoc Biol; 2000 Aug; 68(2):293-300. PubMed ID: 10947075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells.
    Ticchioni M; Deckert M; Mary F; Bernard G; Brown EJ; Bernard A
    J Immunol; 1997 Jan; 158(2):677-84. PubMed ID: 8992983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Galpha11-dependent, PLC-beta-mediated pathway.
    Bueno C; Lemke CD; Criado G; Baroja ML; Ferguson SS; Rahman AK; Tsoukas CD; McCormick JK; Madrenas J
    Immunity; 2006 Jul; 25(1):67-78. PubMed ID: 16860758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire.
    Soares MV; Borthwick NJ; Maini MK; Janossy G; Salmon M; Akbar AN
    J Immunol; 1998 Dec; 161(11):5909-17. PubMed ID: 9834071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant CD3- and CD28-mediated signaling events in cord blood T cells are associated with dysfunctional regulation of Fas ligand-mediated cytotoxicity.
    Sato K; Nagayama H; Takahashi TA
    J Immunol; 1999 Apr; 162(8):4464-71. PubMed ID: 10201983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
    Schnaider T; Somogyi J; Csermely P; Szamel M
    Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the pim-1 protooncogene: differential inducibility between alpha/beta- and gamma/delta-T cells and B cells.
    Wingett D; Stone D; Davis WC; Magnuson NS
    Cell Immunol; 1995 Apr; 162(1):123-30. PubMed ID: 7704900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus.
    Jury EC; Kabouridis PS; Abba A; Mageed RA; Isenberg DA
    Arthritis Rheum; 2003 May; 48(5):1343-54. PubMed ID: 12746907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human T cell activation by novel Src kinase inhibitors is dependent upon the complexity of the signal delivered to the cell.
    Rapecki S; Allen R
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1325-33. PubMed ID: 12438558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective deficiency in protein kinase C isoenzyme expression and inadequacy in mitogen-activated protein kinase activation in cord blood T cells.
    Hii CS; Costabile M; Mayne GC; Der CJ; Murray AW; Ferrante A
    Biochem J; 2003 Mar; 370(Pt 2):497-503. PubMed ID: 12435268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reishi immuno-modulation protein induces interleukin-2 expression via protein kinase-dependent signaling pathways within human T cells.
    Hsu HY; Hua KF; Wu WC; Hsu J; Weng ST; Lin TL; Liu CY; Hseu RS; Huang CT
    J Cell Physiol; 2008 Apr; 215(1):15-26. PubMed ID: 18189229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgD receptor-mediated signal transduction in T cells.
    Lakshmi Tamma SM; Wu Y; Toporovsky I; Lima V; Coico RF
    Cell Immunol; 2001 Feb; 207(2):110-7. PubMed ID: 11243700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
    Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
    Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization and treatment of an oxidation-sensitive defect within the TCR-coupled signalling pathway that is associated with normal and premature immunologic aging.
    Weber GF; Mirza NM; Yunis EJ; Dubey D; Cantor H
    Growth Dev Aging; 1997; 61(3-4):191-207. PubMed ID: 9546110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors.
    Morford LA; Elliott LH; Carlson SL; Brooks WH; Roszman TL
    J Immunol; 1997 Nov; 159(9):4415-25. PubMed ID: 9379040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.